Alimera Sciences Inc.

The team that established CIBA Vision Ophthalmics and later worked together at Novartis Ophthalmics has launched specialty ophthalmologic pharma Alimera Sciences Inc. Alimera has moved its first OTC eye care product to market, and plans to begin development of prescription ophthalmic drugs.